JAN 16, 2020 1:00 PM PST

Babies in Africa Receive World's First Malaria Vaccine

WRITTEN BY: Tiffany Dazet

Would you accept a vaccine that was only 40% effective? For those at risk of malaria, the answer is likely a resounding, "yes!" According to the World Health Organization (WHO), malaria kills more than 400,000 people each year, two-thirds of which are under the age of five. The WHO estimates that one child dies from malaria every two minutes.

The world's first malaria vaccine program was rolled out last year in Malawi, Kenya, and Ghana. Currently, the vaccine is only available to babies in these select regions. However, the ultimate goal is to disperse it throughout Africa.

Although the efficacy of the vaccine is estimated at 40%, the AP reports that experts consider it worthy of an attempt as resistance to treatment is growing. According to the WHO, this first-generation vaccine known as RTS,S/AS01 (RTS,S) acts against Plasmodium falciparum, which is the most deadly malaria parasite worldwide and most prevalent in Africa. Clinical testing occurred in seven African countries and showed promise to prevent malaria. The WHO reports that children who receive four doses of RTS,S suffer "significantly fewer cases of malaria, including severe, life-threatening malaria," when compared to those who did not receive the vaccine.

According to the WHO, the goal of the Malaria Vaccine Implementation Programme (MVIP) is to reach 360,000 children per year in the selected countries. The first vaccine dose is given at about five months of age, then doses two and three at monthly intervals, and the fourth final dose when the child is about two years of age. With this rollout program, stakeholders hope to determine the feasibility of delivering the required four doses, the vaccine's role in reducing deaths, and the vaccine's safety profile.

The AP reports that the development of this vaccine took about 30 years of research, citing the parasite's complex life cycle as a significant hurdle. Ashley Birkett, director of PATH's Malaria Vaccine Initiative, told AP reporters, "We don't have any vaccines against parasites in routine use. This is uncharted territory."

The WHO states that the MVIP is expected to continue through 2022. Additionally, the WHO says that this vaccine was developed specifically for Africa and African children, who "bear the greatest burden of malaria worldwide." Future studies are needed before RTS,S can be considered for use outside of Africa.

Sources: AP News, World Health Organization 

About the Author
  • Tiffany grew up in Southern California, where she attended San Diego State University. She graduated with a degree in Biology with a marine emphasis, thanks to her love of the ocean and wildlife. With 13 years of science writing under her belt, she now works as a freelance writer in the Pacific Northwest.
You May Also Like
AUG 28, 2020
Cancer
Using CRISPR-Cas12a to Repair Hereditary Cancers in the Lab
AUG 28, 2020
Using CRISPR-Cas12a to Repair Hereditary Cancers in the Lab
Genome repair is one of the big-ticket research areas for the future of medicine. CRISPR-Cas9 systems can edit the genom ...
SEP 10, 2020
Cardiology
Many Doctors Have Used the Wrong Criteria to Diagnose Hypertension
SEP 10, 2020
Many Doctors Have Used the Wrong Criteria to Diagnose Hypertension
A recent survey has shown that most health care professionals may not be using the current information to screen for and ...
SEP 11, 2020
Cell & Molecular Biology
How Variants Affect Gene Expression Across Cell Types
SEP 11, 2020
How Variants Affect Gene Expression Across Cell Types
The Genotype-Tissue Expression (GTEx) Consortium, has produced multiple papers that have provided new insight into human ...
SEP 13, 2020
Microbiology
Amazing Images of the Pandemic Virus SARS-CoV-2
SEP 13, 2020
Amazing Images of the Pandemic Virus SARS-CoV-2
Researchers in the lab of Camille Ehre, Ph.D. at the UNC School of Medicine have created amazing images of the pandemic ...
SEP 18, 2020
Space & Astronomy
Scientists Discover Intergalactic Origins of Gold
SEP 18, 2020
Scientists Discover Intergalactic Origins of Gold
Back in 2017, scientists theorized that elements heavier than iron- such as gold- came to be following a collision betwe ...
SEP 21, 2020
Cell & Molecular Biology
The Hormones We Have at Birth Are Linked to Disease Throughout Life
SEP 21, 2020
The Hormones We Have at Birth Are Linked to Disease Throughout Life
New work may help explain why some autoimmune or immune-related diseases are more common in women, who are more likely t ...
Loading Comments...